Life Transitions

More women are using medical cannabis for menopause-related symptoms, according to research recently published in Menopause.

The Women’s Preventive Services Initiative (WPSI) has released a new clinical guideline outlining their recommendations for preventing obesity among women in midlife.

Genevieve Neal-Perry, MD, PhD, sits down with Contemporary OB/GYN to discuss positive data from a recent phase 3 study evaluating fezolinetant (Astellas) for vasomotor symptoms (VMS).

Women with the highest PTSD symptoms level experienced significantly worse rates of change regarding learning and working memory.

New research suggests cumulative exposure to PFAS could increase risk of incident hypertension by 71% among midlife women.

New research from a team of investigators in Europe suggests hormonal changes during menopause could explain up to 10% of the increase in LDL-C associated with the transition to menopause among aging women

An analysis of data from a Cleveland Clinic database indicates calcium supplementation in older adults with aortic stenosis was linked to an increased risk of mortality and worsening aortic stenosis.

Data from a cohort of 5000 patients indicates that NSAID use may negatively affect clodronate therapy in older women.

Data from an analysis of a SWAN substudy suggests increased exposure to PFAS was linked to an increased risk of incident diabetes during midlife among women.

Women with laparoscopically confirmed endometriosis are at significantly higher risk for early natural menopause (ENM), and this risk was greater for nulliparous women and women who never reported using oral contraceptives, according to a study in JAMA Network Open.

A recent study found overweight status in midlife, compared to normal body mass index, was linked to a higher burden of morbidity and greater proportion of life lived with morbidity.

Astellas announced positive data from its study investigating the long-term safety of fezolinetant for the treatment of moderate to severe vasomotor symptoms (VMS) associated with menopause.

More than half of postmenopausal women experience female pattern hair loss, according to a cross-sectional study in the journal Menopause.

Risk assessment, lifestyle counseling, adverse effects, and medication management.

According to a recent study, women who experience stable menstrual cycles during the menopause transition have a significantly higher cardiovascular disease (CVD) risk later in life than those who have a late increase in cycle length.

Midlife women with early-stage vision impairment are significantly more likely to develop depressive symptoms, according to a study in the journal Menopause, which used data from the Michigan site of the Study of Women’s Health Across the Nation (SWAN).

A more standardized approach to menopause preparedness, including educating both patients and providers, is needed to improve care and quality of life for individuals during and after menopause, according to a study in the journal Menopause.

Physical inactivity can exacerbate BMD decline and increase fracture risk.

An evaluation of multiple recommended eating patterns has found that intakes of legumes, dietary fiber, and vegetable protein is linked to lower risk of peripheral arterial disease (PAD), whereas intakes of unprocessed red meat, processed meat, and regular soft drinks are associated with higher risk.

The challenge of diagnosis occurs in distinguishing “normal” from “abnormal” in a time of rapid and dynamic change.

A secondary analysis of the Women’s Health Initiative (WHI)-Calcium and Vitamin D (CaD) clinical trial has concluded that vasomotor symptom severity is not linked to any clinical event.

A prospective study of generally healthy perimenopausal women has concluded that low bone mineral density (BMD) is significantly linked with periodontal disease in women over 58 years old, and independent of tobacco consumption or oral hygiene.

Read about the impact when long-acting reversible contraception (LARC) was offered to teenage mothers prior to hospital discharge.

A peak in hot fl ash reports was observed in July, while January had a trough in hot fl ash reports.

The authors noted that, although recent guidelines embrace using history of menopause before age 40 to refine atherosclerotic cardiovascular disease (ASCVD) risk assessments in middle-aged women, “robust data on cardio-vascular disease risk in this population is lacking.”